Therapy News and Research

RSS

Fatty acid synthase provides new target for treatment of obesity and diabetes

Researchers at Washington University School of Medicine in St. Louis have identified a potential target for treating diabetes and obesity.

3 Aug 2012

Healthpoint Biotherapeutics announces results from HP802-247 Phase 2b trial on venous leg ulcers

Healthpoint Biotherapeutics today announced that the results for its Phase 2b clinical trial investigating the efficacy of HP802-247 in venous leg ulcers is published on The Lancet, beginning August 3, 2012, with Online First access to the article, followed by print publication in the next issue.

3 Aug 2012

Combination of sitagliptin and lansoprazole offers clinical benefits for T1D patients

Sanford Project researchers have reached a critical milestone in a clinical trial testing a combination of two medications to determine if the drugs can help patients with type 1 diabetes (T1D) keep their blood glucose levels under control with less or no insulin. The full number of patients needed to complete this first trial, termed Restore Pancreatic Insulin Response in type 1 diabetes (REPAIR-T1D), has been reached.

2 Aug 2012

BMC to implement and evaluate opioid risk reduction model in primary care settings

Researchers at Boston Medical Center (BMC) have received a $2.67 million grant from the National Institute on Drug Abuse (NIDA) to implement and evaluate a new model of care in primary care settings aimed at decreasing the misuse of and addiction to opioids among patients with chronic pain.

2 Aug 2012

PTSD prevalent in serious mental illness patients

Post-traumatic stress disorder is common among patients with serious mental illnesses, and is associated with an increased risk for suicide attempts, Spanish researchers report.

2 Aug 2012

OCS common in patients at high risk for psychosis

Obsessive–compulsive symptoms are common in patients at high risk for psychosis and are associated with an increased risk for suicidal ideation, US study results show.

2 Aug 2012

MDCH unveils Michigan’s Infant Mortality Reduction Plan

The Michigan Department of Community Health (MDCH) has unveiled the state's Infant Mortality Reduction Plan, a strategy that includes significant recommendations developed from medical research conducted by the Perinatology Research Branch (PRB) of the Eunice Kennedy Shriver National Institute for Child Health and Human Development, National Institutes of Health (NICHD/NIH), at the Wayne State University School of Medicine.

2 Aug 2012

Combination hormonal therapy improves survival in advanced breast cancer

A study co-authored by a Loyola researcher and published in the New England Journal of Medicine is offering new hope to women with advanced breast cancer.

2 Aug 2012

New insight into why glioblastoma multiforme recurs in adults

A study by UT Southwestern Medical Center researchers published online today in Nature reveals new insight into why the most common, deadly kind of brain tumor in adults recurs and identifies a potential target for future therapies.

2 Aug 2012

Combination of anastrozole and fulvestrant extends survival in women with metastatic breast cancer

Results of a SWOG clinical trial published August 2 in the New England Journal of Medicine show the combination of anastrozole and fulvestrant extended the median survival time of women with hormone receptor-positive metastatic breast cancer by more than six months compared to women treated with a standard therapy of anastrozole alone (47.7 months vs 41.3 months).

2 Aug 2012

Possible molecular link between circadian rhythm disturbances and increased inflammatory response

Scientists have known for some time that throwing off the body's circadian rhythm can negatively affect body chemistry. In fact, workers whose sleep-wake cycles are disrupted by night shifts are more susceptible to chronic inflammatory diseases such as diabetes, obesity and cancer.

2 Aug 2012

Researchers develop bioactive coating that actively suppresses brain's immune response

Brain-computer interfaces are at the cutting edge for treatment of neurological and psychological disorder, including Parkinson's, epilepsy, and depression. Among the most promising advance is deep brain stimulation (DBS) - a method in which a silicon chip implanted under the skin ejects high frequency currents that are transferred to the brain through implanted electrodes that transmit and receive the signals.

1 Aug 2012

Miami Project to Cure Paralysis receives FDA permission to begin Phase 1 trial

The Miami Project to Cure Paralysis, a Center of Excellence at the University of Miami Miller School of Medicine, has received permission from the Food and Drug Administration to begin a revolutionary Phase 1 clinical trial to evaluate the safety of transplanting human Schwann cells to treat patients with recent spinal cord injuries.

1 Aug 2012

Therapy News and Research

Fatty acid synthase provides new target for treatment of obesity and diabetes

Healthpoint Biotherapeutics announces results from HP802-247 Phase 2b trial on venous leg ulcers

Combination of sitagliptin and lansoprazole offers clinical benefits for T1D patients

BMC to implement and evaluate opioid risk reduction model in primary care settings

PTSD prevalent in serious mental illness patients

OCS common in patients at high risk for psychosis

MDCH unveils Michigan’s Infant Mortality Reduction Plan

Combination hormonal therapy improves survival in advanced breast cancer

New insight into why glioblastoma multiforme recurs in adults

Combination of anastrozole and fulvestrant extends survival in women with metastatic breast cancer

Possible molecular link between circadian rhythm disturbances and increased inflammatory response

Researchers develop bioactive coating that actively suppresses brain's immune response

Miami Project to Cure Paralysis receives FDA permission to begin Phase 1 trial

Shampoo effective for pruritus relief in dogs

Gene discovery made for infant-onset blindness

ART resistance increasing in sub-Saharan Africa

Breast cancer drug bevacizumab (Avastin): an interview with Dr Anna Dorothea Wagner

Intraluminal protection device outperforms two negative-pressure IV connectors in MECH research

Minimally invasive approach during coronary artery bypass grafting surgery is safe and effective

Researchers discover new approach to treat two lethal metastatic cancers

Industry Focus eBook - Cell biology (5th edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News